ARTES and Basic Pharma near completion of their joint rHSA project

Geleen – Langenfeld, May 2024 ARTES Biotechnology and Basic Pharma are almost there! The companies are nearing completion of their joint project with the production of recombinant Human Serum Albumin (rHSA) and the first vials are expected to be available this summer. ARTES, a leading company that specialized in developing and transferring recombinant cell lines […]

ARTES announce expansion of the management board

Langenfeld, Germany; 10th of January 2024 ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director. Volker […]

ARTES and Basic Pharma join in a strategic Collaboration

  ARTES Biotechnology and Basic Pharma join in a strategic Collaboration and Co-Marketing Partnership for Pharmaceutical Recombinant Protein Production Geleen – Langenfeld, October 2023 ARTES Biotechnology, a leading company specializing in development and transfer of recombinant cell lines and protein production processes from microbial expression systems and Basic Pharma, a pharmaceutical company focusing on niche […]

ARTES’ Proteins for Diagnostics

New Paper Published